Home>Topics>Stocks>JMP Group


  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. Headlines
    1. IPO Preview: ProQR Therapeutics


      Thu, 18 Sep 2014

      available at IPOpremium SEC Documents Manager, Co-managers: Leerink Partners, Deutsche Bank Securities Joint-managers: JMP Securities, H.C. Wainwright & Co., LLC End of lockup (180 days): Tuesday 17, 2015 End of 25-day quiet period: Tuesday

    2. ProQR Therapeutics: Competition, Distance From Clinical Trials Leads Us To Hold Off


      Tue, 16 Sep 2014

      2014 Lead Underwriters: Deutsche Bank Securities Inc; Leerink Partners LLC Underwriters: H.C. Wainwright & Co., LLC; JMP Securities Valuation PRQR offers the following figures in its F-1 balance sheet for the six months ended June 30, 2014: Revenue

    3. Orexigen Therapeutics' (OREX) CEO Mike Narachi Hosts Conference Call (Transcript)


      Thu, 11 Sep 2014

      Development Analysts Charles Duncan - Piper Jaffray Cory Kasimov - JPMorgan Steve Byrne - Bank America Merrill Lynch Jason Butler - JMP Securities Matthew Andrews - Wells Fargo Securities Presentation Operator Welcome to the Orexigen Therapeutics Conference Call

    4. Parkway Properties splits CFO and CIO duties


      Tue, 9 Sep 2014

      yesterday. The new CIO is Jason Bates who joined the company in 2011 and has been SVP Head of Transactions since last November. Source: Press Release Previously: Columbia Property boosted, Parkway Properties cut at JMP Post your comment!

    5. Columbia Property boosted, Parkway Properties cut at JMP


      Tue, 9 Sep 2014

      It's a pairs trade of sorts from JMP Securities, which upgrades Columbia Property Trust (NYSE: CXP ) to Outperform from Market Perform, while cutting Parkway Properties

    6. Keryx Biopharmaceuticals' (KERX) CEO Ron Bentsur Discusses FDA approval of Ferric Citrate (Transcript)


      Mon, 8 Sep 2014

      CEO Greg Madison - COO James Oliviero - CFO Analyst Matthew Kaplan - Ladenburg Thalmann Whitney Ijem - JPMorgan Mike King - JMP Security Joe Pantginis - ROTH Capital Partner Mario Corso - Mizuho Jason Kolbert - Maxim Stephen Willey - Stifel Andrew Barrens

    7. MeetMe +4.1% after JMP coverage launch


      Thu, 21 Aug 2014

      JMP has launched coverage on MeetMe (NASDAQ: MEET ) with an Outperform and $3 target. Wunderlich launched coverage with a Buy two months ago, while predicting strong continued growth in mobile active users and monetization. Post your comment!

    8. Calling All Activist Investors: Liquidate This Fund


      Fri, 15 Aug 2014

      NYSE: YUM ), 7% to Wal-Mart (NYSE: WMT ), and the rest of its funds to large companies like J.P. Morgan (NYSE: JMP ) Wells Fargo (NYSE: WFC ), and Cisco (NASDAQ: CSCO ). While this fund may serve as a great proxy to those who want to

    9. JGWPT Holdings' (JGW) CEO Stewart Stockdale on Q2 2014 Results - Earnings Call Transcript


      Thu, 14 Aug 2014

      Head of Investor Relations Stewart Stockdale – CEO John Schwab – EVP & CFO David Miller – Former CEO Analysts David Scharf – JMP Securities Moshe Orenbuch – Credit Suisse Terry Ma – Barclays Capital Yaron Kinar – Deutsche Bank Sanjay Sakhrani – KBW Josh

    10. Epizyme (EPZM) CEO Robert Gould on Q2 2014 Results - Earnings Call Transcript


      Wed, 13 Aug 2014

      Gould - CEO Jason Rhodes - President and CFO Eric Hedrick - Chief Medical Officer Robert Copeland - CSO Analysts Mike King - JMP Securities Howard Liang - Leerink Swann Presentation Operator Good day ladies and gentlemen and welcome to the Q2, 2014 Epizyme

    « Prev12345Next »
    Content Partners